On August 7, Oklo Inc. rose 5.05% in pre-market trading, trading at $44.35 per share, with turnover of approximately $2.88 million.
On the news front, the U.S. Department of Energy announced that Oklo's small nuclear reactor has achieved \"criticality\" status, marking a critical milestone on the company's path toward advanced nuclear energy commercialization. In July, Oklo's Groves Isotope Test Reactor had received DOE startup authorization and documented safety analysis approval, with the company explicitly targeting first criticality as a near-term objective. That goal has now been formally achieved.
Additionally, the company is scheduled to release quarterly earnings today. Market consensus expects adjusted earnings per share of -$0.17, representing a year-over-year improvement. Revenue is projected at approximately $126,300, remaining largely flat. The company previously secured a letter of intent with Centrus Energy for high-assay low-enriched uranium supply to support its planned 1.2-gigawatt campus, with deliveries expected to begin in 2029.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments